-transparent.png){kind=logo}
A series of (omega-piperazinylalkoxy)indan derivatives has been synthesized and screened for potential antianxiety activities. The effect of structural modification of these molecules on activities has been systemically examined. Antianxiety activity was displayed by 5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (2), 5-[3-[4-(4-fluorophenyl)-1-piperazinyl]-propoxy]indan (8), 6-fluoro-5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (33), and 6-methyl-5-[3-(4-phenyl-1-piperazinyl)propoxy]indan (42), as determined in antifighting and anti-morphine tests. These derivatives in antianxiety tests were equipotent or more potent than chlordiazepoxide with less muscle-relaxant effect. They also showed weak neuroleptic-like action.
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
February 2006,
Yao xue xue bao = Acta pharmaceutica Sinica,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
September 2009,
European journal of medicinal chemistry,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
May 1985,
Journal of pharmaceutical sciences,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
November 1985,
Journal of medicinal chemistry,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
June 1994,
Journal of medicinal chemistry,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
September 2021,
ACS medicinal chemistry letters,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
February 2021,
SAR and QSAR in environmental research,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
January 1982,
Pharmacology, biochemistry, and behavior,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
February 2004,
Archiv der Pharmazie,
R Kikumoto, and
A Tobe, and
H Fukami, and
M Egawa
November 1970,
Journal of medicinal chemistry,
